Contact Information
Phone:
—
Email:
Selected publications
Kelley Hutchins
Biography
Kelley Hutchins, DO, MPH, is a pediatric hematologist-oncologist at Kapi’olani Medical Center for Women & Children. She is a graduate of Des Moines University College of Osteopathic Medicine. Dr. Hutchins completed a residency in internal medicine/pediatrics at Louisiana State University. She then completed a fellowship in pediatric hematology/oncology at Children’s Hospital of Michigan and is board certified in pediatrics, internal medicine and pediatric hematology/oncology.
Dr. Hutchins' research interests span various areas of hematology, oncology and survivorship. In 2021-2022, she completed the Biomedical Research & Innovation Center (BRIC) Clinical Research Training, where her project focused on patient care satisfaction for adolescent and young adults with cancer. Through her research endeavors, Dr. Hutchins aims to advance understanding, treatment, and care for patients with cancer and survivors alike.
Research Interests
Pediatric oncology
Cardiotoxicity and its long-term effects on pediatric cancer survivors
Survivorship care and follow-up in childhood cancer survivors
Genetic abnormalities in pediatric leukemia and associated syndromes
Cardiovascular health in survivors of childhood cancer
Projects
No active projects.
Bagley S, Umemura Y, Mendez JS, Arrillaga-Romany I, Bielamowicz KJ, Butowski N, Hutchins K, Kong XT, Odia Y, Sharma A, Weintraub L, Koschmann C, Wen P, Saratsis AM, Brundage T, Ramage SC, Tarapore T, Knowles T, Yang D, Allen J, Cloughesy. H3K27M Mutant Glioma: Natural Disease History and Prognostic Features. Submitted Neuro-Oncology 2023, under review.
Bansal N, Joshi C, Adams MJ, Hutchins K, Ray A, Lipshultz SE. Cardiotoxicity in pediatric lymphoma survivors. Expert Rev Cardiovasc Ther. 2021 Nov;19(11):957-974. doi: 10.1080/14779072.2021.2013811. Epub 2021 Dec 27. PMID: 34958622.
Hutchins KK, Steiner R, Lipshultz E, Sallan SE, Lipshultz SE. (2021). Cardiotoxicity after Childhood Cancer Treatment. Late Treatment Effects and Cancer Survivor Care in the Young. Switzerland: Springer. pp. 3-15.
Abe K, Dowsett L, Wada R, Hutchins K. A pediatric case of acute myeloid leukemia with KMT2A gene rearrangement t(10;11) and 16p11.2 microdeletion syndrome. Pediatr Blood Cancer. 2021 Feb;68(2):e28764. doi: 10.1002/pbc.28764. Epub 2020 Oct 15.
Hutchins KK, Savasan S, Thomas RL, Strathdee LA, Wang ZJ, Taub JW. Clinical Trial Enrollment is Associated with Improved Follow-up Visit Rates among Survivors of Childhood Cancer; J Pediatr Hematol Oncol. 2018. doi: 10.1097/MPH.0000000000001169.
Link to the complete list of publications:
https://pubmed.ncbi.nlm.nih.gov/?term=Hutchins+KK&cauthor_id=29668542